{ Banner Photo }

Secret Rebates Erode Drugmaker Revenue, Industry Study Says

January 18, 2017
Robert Langreth
Bloomberg Business

Aaron Vandervelde comments on branded drug companies’ share of total US spending on their products and other topics discussed in the paper The Pharmaceutical Supply Chain: Gross Drug Expenditures Realized by Stakeholders, which he coauthored with Eleanor Blalock.

Read the article.

Related Professionals